Wednesday, June 20, 2018


How the Government Can Lower Drug Prices

Scholarship by Professor of Law Amy Kapczynski ’03, Hannah Brennan ’13, Christine Monahan ’16, and Zain Rizvi ’17 is cited in a commentary about ways the federal government could curb rising drug prices.

Wednesday, April 25, 2018


Clock ticking on a bipartisan scramble to curb drug costs

A report by the Global Health Justice Partnership is cited in an article on controlling prescription drug costs.

Wednesday, March 21, 2018


Trump’s pick to lead CDC both celebrated and censured

Associate Professor (Adjunct) of Law Gregg Gonsalves is quoted in an article about the next director of the U.S. Centers for Disease Control and Prevention.

Monday, February 19, 2018


Sienna Merope-Synge Discusses U.N. Accountability in Haiti

Sienna Merope-Synge, a Staff Attorney at the Institute for Justice & Democracy in Haiti (IJDH), spoke on February 12 about her organization's fight to secure adequate remedies for victims of the U.N.'s introduction of a 2010 cholera epidemic in Haiti.

Friday, February 9, 2018


When the State Fails: Maternal Mortality and Racial Disparity in Georgia

The Global Health Justice Partnership released a report asserting that Georgia is failing its obligations to women by perpetuating a maternal mortality crisis disproportionally impacting Black women.

Tuesday, January 16, 2018


GHJP Works to Address the Skyrocketing Cost of Medicines

As Yale Law School’s Global Health Justice Partnership works to reform prescription drug pricing, its ideas are having a national impact.

Tuesday, November 21, 2017


Three things Trump can do to bring drug prices ‘way down’—A Commentary by Amy Kapczynski ’03 and Aaron S. Kesselheim

Amy Kapczynski is a Professor of Law at Yale Law School, Faculty Co-Director of the Global Health Justice Partnership, and Faculty Co-Director of the Collaboration for Research Integrity and Transparency. Aaron Kesselheim is an Irving S. Ribicoff Visiting Associate Professor of Law at Yale Law School and a Distinguished Visitor at the Solomon Center for Health Law and Policy.

Wednesday, November 8, 2017


Amgen Challenge of FDA Decision on Pediatric Exclusivity Could Have Wider Implications

Research Scholar in Law and Research Fellow Jeannie Kim is quoted, and the Collaboration for Research Integrity and Transparency mentioned, in a story about an FDA decision regarding the exclusivity of a drug marketed by Amgen.

Tuesday, September 19, 2017


GHJP Closes Two-Year FOIA Case Against Drug Manufacturer

The Global Health Justice Partnership (GHJP) at Yale Law School and the Yale School of Public Health ended a two-year Freedom of Information Act (FOIA) case, winning an important victory for clinical research transparency.

Tuesday, August 29, 2017


Cutbacks in Foreign Aid for HIV Treatment Would Cause Great Harm, Generate Few Savings

Proposed reductions in U.S. foreign aid would have a devastating impact on HIV treatment and prevention programs in countries receiving such aid, an international team of investigators reports.

Pages